Condition category
Circulatory System
Date applied
Date assigned
Last edited
Prospectively registered
Overall trial status
Recruitment status

Plain English Summary

Background and study aims
Coronary heart disease (CHD) affects over 2.3 million people in the UK. There is a very large cost to both the individual, in terms of loss of quality of life, and to society, in terms of healthcare costs and loss of productivity. It has been estimated that the cumulative cost of cardiovascular disease (CVD) to the UK economy is about £30 billion per year. The management of people with CHD has been outlined in many national and international guidelines and acknowledges the importance of cardiac rehabilitation (CR). CR is a programme of exercise and information sessions to help patients after a heart attack, heart surgery or procedure. Despite national guidance a significant number of eligible patients do not receive or take up the offer of CR. Factors related to nonattendance include employment commitments, difficulties with transport, lack of time, distance to travel to rehabilitation, and embarrassment related to attending group rehabilitation sessions. This study will assess the feasibility of delivering an alternative web-based CR intervention ('Activate your Heart') for those who decline or drop out from conventional supervised CR. Our program has not yet been tested with these groups and therefore we are aiming to examine the practicalities of conducting a large scale study with this population.

Who can participate?
Adult patients (aged over 18) with a confirmed diagnosis of CHD who have recently declined or dropped out of conventional CR.

What does the study involve?
Participants will be randomly allocated to one of two groups: the web-based CR group or the control group. Those allocated to web-based CR will have access to the 'Activate your Heart' online programme for 12 months (although the programme can be completed within 4 weeks). The programme is individually tailored and supervised by the local CR team. Patients in the control group will recieve usual care for their region: a referral back to general practice and standard advice and guidance booklets.

What are the possible benefits and risks of participating?
There may not be any direct benefit to participants. However, we would hope that taking part in the research may help patients' understanding of exercise and rehabilitation and inform both present and future cardiac rehabilitation programmes, therefore benefiting other CHD patients. There are minimal identified risks to taking part in this study. Patients experience some muscle aching and general tiredness after performing the walking tests and if allocated to the web-based exercise programme. This is usually mild and wears off after a couple of days. Participants in the control group will not receive any form of rehabilitation. This would be standard care if you declined rehabilitation classes or dropped out during a conventional CR programme. Participants will be asked to make additional visits to hospital over the 6-month study period. This is a potential inconvenience but, in our experience, most patients are happy to attend. Travel expenses will be reimbursed or a taxi provided for these assessment visits.

Where is the study run from?
University Hospitals of Leicester (UHL) NHS Trust and Lincoln Community Health Service NHS Trust (UK)

When is the study starting and how long is it expected to run for?
The study has started and should end by October 2017. We anticipate starting recruitment in December 2015. Overall a participant will be involved in the study for up to 6 months, although the study will go on for much longer.

Who is funding the study?
The study is being funded by the Research for Patient Benefit (RFPB) programme, which is part of the funding body National Institute for Health Research (NIHR). The study is also supported by the NIHR Leicester Respiratory Biomedical Research Unit (BRU).

Who is the main contact?
1. Prof. Sally Singh (
2. Charlotte Martin (

Trial website

Contact information



Primary contact

Prof Sally Singh


Contact details

Centre for Exercise and Rehabilitation Science (CERS)
Respiratory BRU
Glenfield Hospital
Groby Road
United Kingdom
+44 (0)116 250 2350



Additional contact

Ms Charlotte Martin


Contact details

Bourne Health Clinic
St Gilberts Road
PE10 9XA
United Kingdom
+44 (0)1778 425124

Additional identifiers

EudraCT number number

Protocol/serial number

Research for Patient Benefit (RfPB) Programme: PB-PG-1013-32059

Study information

Scientific title

A Web-based cardiac REhabilitatioN alternative for those declining or dropping out of conventional rehabilitation: the WREN feasibility study



Study hypothesis

The study is a feasibility randomised controlled trial, which aims to assess the feasibility of delivering an alternative web-based Cardiac Rehabilitation (CR) intervention for those who decline or drop out from conventional supervised CR.

Ethics approval

NRES Committee East Midlands - Leicester Central, 06/08/2015, REC ref: 15/EM/0291

Study design

Feasibility randomised controlled trial

Primary study design


Secondary study design

Randomised controlled trial

Trial setting


Trial type


Patient information sheet

Not available in web format, please use contact details below to request a patient information sheet.


Coronary heart disease (CHD)


Intervention group: web-based cardiac rehabilitation using the 'Activate your Heart' online programme.
Control group: usual care.

Intervention type



Drug names

Primary outcome measures

The primary outcome measure in this study is to assess the feasibility of recruiting/retaining people who meet our inclusion and exclusion criteria; those who have declined/dropped out of traditional cardiac rehabilitation.

Secondary outcome measures

1. Feasibility of our randomisation process and willingness to be randomised
2. Retention rate of participants to the study at 8 weeks, and 6 months follow-up
3. Feasibility of conducting outcome measures which are proposed for the final trial:
3.1. Health-related quality-of-life; 'MacNew Heart Disease Questionnaire', measuring physical, emotional, and social aspects of quality-of-life
3.2. Exercise Capacity; measured using the ‘Incremental Shuttle Walking Test (ISWT)’, which is a test used to assess cardio-respiratory fitness
3.3. Anxiety and Depression; measured using the ‘Hospital Anxiety and Depression Scale (HADS)'
3.4. Self-efficacy; measured using ‘The General Self-Efficacy Scale'
3.5. In order to conduct an economic evaluation, impact on health utility will be assessed using the 'EQ-5D' questionnaire. This measures health on five dimensions and a tariff is available for deriving a single utility score based on time trade-off utility scores
3.6. 'Seattle Angina Questionnaire' (SAQ)
3.7. Angina Symptoms; Symptoms and medication use diary kept by the patient for 2 week, recording the frequency of episodes of angina and the number of glyceryl trinitrate (GTN) pills or ‘puffs’ of sub-lingual spray taken each day
3.8. Web usage: weekly and total web usage statistics for patients assigned to the web-based programme will be monitored as will any technical problems participants encounter
3.9. Intervention completion rates amongst intervention group participants

Outcomes will be assessed at baseline, 8 weeks and 6 months in both groups.

Overall trial start date


Overall trial end date


Reason abandoned


Participant inclusion criteria

1. Confirmed primary diagnosis of coronary heart disease (CHD)
2. Eligible for conventional CR (eligibility as described in NICE CR commissioning guidelines 2013, section 3)
3. Access to internet. Questions will be asked to establish familiarity with the internet, e.g. use of either online shopping/online banking
4. People who have recently (<12 months) declined an invitation to rehabilitation. These people are defined as those at stage 2 (patient assessment) or stage 3 (when the patient care plan is developed) expressing an unwillingness to attend any further stages of the programme (stages defined in NICE commissioning guidelines 2013, section 1). People who prospectively decline at these stages will also be included
5. People who have recently (<12 months) ‘dropped-out’ of rehabilitation. These people are defined as those not attending 2 consecutive sessions of stage 4 comprehensive rehabilitation sessions (stages defined in NICE commissioning guidelines 2013, section 1)

Participant type


Age group




Target number of participants

60 (30 per site). In addition we will aim to recruit between 16- 20 participants (14 patients and 6 members of staff) for the qualitative interviews

Participant exclusion criteria

1. No access to the internet (it would be unrealistic to recruit people without access to the internet; it is beyond the scope of the project to provide the hardware to participants)
2. Individuals who have completed rehabilitation for a previous admission in the last 12 months
3. Those demonstrating high levels of depression (defined by baseline HADS score >11 [moderate depression]) and poor exercise capacity (defined by poor performance on the Incremental Shuttle Walking Test, level achieved <3 – equivalent to walking 120 metres). These patients will require a more supervised approach
4. Unable to read English. The website is currently only available in English

Recruitment start date


Recruitment end date



Countries of recruitment

United Kingdom

Trial participating centre

University Hospitals of Leicester NHS Trust
Trust Headquarters Gwendolen House Gwendolen Road
United Kingdom

Trial participating centre

Lincoln Community Health Service NHS Trust
NG34 8GG
United Kingdom

Sponsor information


University Hospitals of Leicester NHS Trust

Sponsor details

Research and Development Office
Leicester General Hospital
Gwendolen Road
United Kingdom

Sponsor type

Hospital/treatment centre



Funder type


Funder name

National Institute for Health Research

Alternative name(s)


Funding Body Type

government organisation

Funding Body Subtype

Federal/National Government


United Kingdom

Results and Publications

Publication and dissemination plan

The primary aim of the study is to inform a definitive trial; we would disseminate the data widely with stakeholders to collaborate and inform a clinical effectiveness trial. We will share the results of the feasibility study with local primary and secondary care groups, such as commissioning teams and service managers, service users and service providers. We intend to publish the protocol and also propose to report the study outcomes in academic/health service journals. We would engage with our PPI group and local patient charities to compile appropriate reports and outcomes of the study and use these groups to disseminate our results. We would engage with the communications departments of the acute trusts and universities participating in the study. The project will be supported by the East Midlands CLAHRC, having communication officers to support local and national dissemination. We will inform national leaders for cardiac rehabilitation of the findings and present the case for a larger, robust clinical trial through the British Association for Cardiovascular Prevention and Rehabilitation (BACPR) annual conference. The team are well connected to disseminate through these pathways.

Intention to publish date

Participant level data

Available on request

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes

On 02/03/2016 the overall trial end date was changed from 15/02/2017 to 07/10/2017.